Diabetes is a huge burden in China, where about 100 million people have been diagnosed with the disease. Treatments are needed that are optimal for treating Chinese patients with diabetes. Chinese patients with type 2 diabetes are characterised by having relatively low bodyweight and significant β-cell deterioration. β-cell failure results in deficiency of insulin secretion, particularly at the early phase of insulin secretion in Chinese patients. As a result, postprandial hyperglycaemia is more pronounced in Chinese patients with early type 2 diabetes than most other ethnic groups.
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/feature-article/early-therapy-type-2-diabetes-china
[2] http://admin.indiaenvironmentportal.org.in/category/author/wenying-yang
[3] http://admin.indiaenvironmentportal.org.in/category/author/jianping-weng
[4] http://admin.indiaenvironmentportal.org.in/category/journal/lancet-diabetes-endocrinology
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/diabetes
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/china
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health-care
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/diagnostic-methods
